FdaApplication
NDA 215025
Identifiers
- fda_app_no: NDA215025
Properties
| Property | Value |
|---|---|
| applicant_name | MAIA PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2021-06-10 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SODIUM PHENYLACETATE AND SODIUM BENZOATE | SODIUM BENZOATE; SODIUM PHENYLACETATE | 10%;10% (2GM/20ML | SOLUTION;INTRAVENOUS |
1 product